Application of the ORBIT Protocol for Targeted Gene Deletion to Mycobacterium abscessus

Bacteria are masters of survival, constantly evolving to withstand the medicines designed to kill them. Among the most formidable of these are the mycobacteria, a family of tough, waxy-coated microbes that includes the organism responsible for tuberculosis. A close relative, Mycobacterium abscessus, has emerged as a particularly dangerous foe, causing severe lung and skin infections that are notoriously difficult to treat. This bacterium carries a natural, built-in resistance to many antibiotics, making standard therapies often ineffective. To understand how this pathogen survives and to find new ways to stop it, scientists need to study its genes. They must be able to turn specific genes off, one by one, to see what happens to the bacteria when that genetic instruction is missing. However, doing this in M. abscessus is like trying to edit a document in a language you do not fully speak; the tools that work perfectly on other bacteria often fail here, leaving researchers unable to get the precise results they need.

A team of researchers at Rutgers Health has now refined a powerful genetic tool called ORBIT to work reliably with Mycobacterium abscessus. The ORBIT system acts like a molecular scalpel, allowing scientists to delete specific sections of the bacterial genome with high precision. The process involves two main steps: first, a helper plasmid is introduced to the bacteria to provide the internal machinery needed to accept new genetic material. This plasmid encodes the specific enzymes, Che9c phage RecT annealase and Bxb1 phage integrase, that facilitate the editing process. Second, a custom-made piece of genetic code, known as an oligonucleotide, is delivered along with a "payload" plasmid. This oligonucleotide is designed to match the DNA surrounding the target gene, guiding the bacterial machinery to swap out the unwanted gene for the payload, which carries a marker to identify successful edits. While this system had been successfully used on other mycobacteria, the researchers found that simply applying the existing instructions to M. abscessus did not work. The bacteria were too resistant to the standard selection markers, and the genetic guides were not precise enough to yield clean results.

The researchers began by tackling the issue of selection. In their initial attempts to delete a specific gene, they used a marker that made the bacteria resistant to an antibiotic called hygromycin. They expected that only the bacteria with the successful gene deletion would survive when placed on a plate containing this drug. Instead, the entire population of bacteria grew, regardless of whether they had been edited. This happened because M. abscessus naturally resists hygromycin, rendering the selection process useless. The team realized they had to find a different antibiotic that the bacteria could not resist on their own. They switched to a drug called zeocin. When they used a payload plasmid carrying a zeocin-resistance marker, the results changed dramatically. Only the bacteria that had successfully incorporated the new genetic material survived, allowing the researchers to isolate and study the correct mutants.

Next, the team focused on the quality of the genetic guides themselves. The ORBIT method relies on long strands of synthetic DNA, called oligonucleotides, to guide the gene deletion. The researchers tested two versions: a shorter strand and a longer one. In theory, longer strands should work better because they match the target DNA more extensively, but the chemical process used to build them often results in a mixture of perfect strands and broken, incomplete ones. The longer the strand, the higher the chance of these errors. To solve this, the researchers used a purification technique called PAGE to filter out the broken strands and keep only the perfect, full-length guides. When they compared the results, the shorter, unpurified guides produced many bacterial colonies, but only a small fraction of them had the correct gene deletion. In contrast, the longer, purified guides produced far fewer colonies overall, but an impressive three out of every four colonies screened contained the exact deletion the scientists wanted. This finding showed that quality mattered far more than quantity; a smaller number of perfect guides led to much more reliable results.

The researchers also discovered that the layout of the bacterial genome required careful attention. When they tried to delete a specific gene, they noticed that the end of that gene overlapped with the beginning of a neighboring gene on the opposite strand. If they deleted the entire target gene as originally planned, they would accidentally damage the neighbor, making it impossible to tell if the observed effects were due to the loss of the target gene or the neighbor. To fix this, they redesigned their genetic guides to leave that small, overlapping section intact. This allowed them to remove the target gene while preserving the integrity of the adjacent gene. This adjustment highlighted a crucial lesson: successful genetic editing requires a deep understanding of the specific architecture of the organism's genome, not just a generic application of a protocol.

Finally, the team confirmed that their optimized method worked across the board. They applied their refined workflow to delete four additional genes, including those involved in the bacteria's resistance to antibiotics. In every case, the combination of the correct antibiotic selection, the use of longer, purified genetic guides, and the careful design of the deletion boundaries allowed them to generate the desired mutants. They also developed a set of specific tests to verify that the edits were correct, ensuring that the bacteria had not accidentally integrated the new DNA in the wrong place or only partially. By establishing this robust and adaptable framework, the researchers have provided the scientific community with a reliable way to manipulate the genes of this difficult pathogen. This advancement opens the door to deeper investigations into how M. abscessus causes disease and resists treatment, offering a clearer path toward developing new strategies to combat these persistent infections.